6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
8m ago	Civeo Corporation Amends Credit Agreement, Increasing Capacity and Extending Maturity to 2030
8m ago	UNIFI®, Makers of REPREVE®, Schedules Third Quarter Fiscal 2026 Earnings Conference Call
9m ago	Butterfield Reports First Quarter 2026 Results
9m ago	Oklo Announces Date for First Quarter 2026 Financial Results and Business Update Call
9m ago	CF Industries Holdings, Inc. Declares Quarterly Dividend

About

Arrivent Biopharma, Inc. Common Stock (NASDAQ:AVBP) — investor relations, events, news, and company updates on 6ix.

Latest News

ArriVent to Present Two Preclinical Posters on the EGFR Inhibitor Firmonertinib and on the Novel dual-target MUC16/NaPi2b Tetravalent ADC ARR-002 at the 2026 AACR Annual Meeting

ArriVent BioPharma Reports Full Year 2025 Financial Results

ArriVent Announces First Patient Dosed in Global Pivotal Phase 3 ALPACCA Trial Evaluating Firmonertinib for First-Line Treatment of EGFR PACC Mutant Non-Small Cell Lung Cancer

ArriVent BioPharma Reports Third Quarter 2025 Financial Results

ArriVent Appoints Brent S. Rice as Chief Commercial Officer

Financials

Revenue

$0

Market Cap

$1.1 B

EPS

-4.32

Community Chat

Ask AI